CA2013571A1 - Vaccins contre bordetella - Google Patents

Vaccins contre bordetella

Info

Publication number: CA2013571A1
Authority: CA; Canada
Prior art keywords: protein; kda; outer membrane; avium; microbe
Prior art date: 1989-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2013571

Other languages

English (en)

Inventor

Jean-Luc Boucaud

Curtiss Roy, Iii

Claudia Gentry-Weeks

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Washington University in St Louis WUSTL

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-31

Filing date

1990-03-30

Publication date

1990-09-30

1990-03-30 Application filed by Individual filed Critical Individual

1990-09-30 Publication of CA2013571A1 publication Critical patent/CA2013571A1/fr

Status Abandoned legal-status Critical Current

Links

241000588807 Bordetella Species 0.000 title claims abstract description 46
229960005486 vaccine Drugs 0.000 title claims abstract description 34
108090000623 proteins and genes Proteins 0.000 claims abstract description 215
102000004169 proteins and genes Human genes 0.000 claims abstract description 146
101710116435 Outer membrane protein Proteins 0.000 claims abstract description 58
238000000034 method Methods 0.000 claims abstract description 43
239000000203 mixture Substances 0.000 claims abstract description 28
241000588851 Bordetella avium Species 0.000 claims description 83
108020004414 DNA Proteins 0.000 claims description 50
239000013598 vector Substances 0.000 claims description 36
241000894006 Bacteria Species 0.000 claims description 33
239000012634 fragment Substances 0.000 claims description 32
108091026890 Coding region Proteins 0.000 claims description 25
239000012528 membrane Substances 0.000 claims description 21
230000014509 gene expression Effects 0.000 claims description 18
108090000765 processed proteins & peptides Proteins 0.000 claims description 18
102000004196 processed proteins & peptides Human genes 0.000 claims description 17
101710088194 Dehydrogenase Proteins 0.000 claims description 15
229920001184 polypeptide Polymers 0.000 claims description 15
230000001717 pathogenic effect Effects 0.000 claims description 13
241000607142 Salmonella Species 0.000 claims description 12
108060000200 adenylate cyclase Proteins 0.000 claims description 11
102000030621 adenylate cyclase Human genes 0.000 claims description 11
241001135529 Bordetella sp. Species 0.000 claims description 9
101710154303 Cyclic AMP receptor protein Proteins 0.000 claims description 9
208000023504 respiratory system disease Diseases 0.000 claims description 2
239000000427 antigen Substances 0.000 abstract description 80
102000036639 antigens Human genes 0.000 abstract description 80
108091007433 antigens Proteins 0.000 abstract description 80
241000287828 Gallus gallus Species 0.000 abstract description 14
235000013330 chicken meat Nutrition 0.000 abstract description 14
201000010099 disease Diseases 0.000 abstract description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
201000005702 Pertussis Diseases 0.000 abstract description 7
241000282898 Sus scrofa Species 0.000 abstract description 3
206010039083 rhinitis Diseases 0.000 abstract description 2
208000011479 upper respiratory tract disease Diseases 0.000 abstract description 2
241000282472 Canis lupus familiaris Species 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 55
241000588724 Escherichia coli Species 0.000 description 38
238000003119 immunoblot Methods 0.000 description 22
230000001580 bacterial effect Effects 0.000 description 21
210000004379 membrane Anatomy 0.000 description 20
239000000523 sample Substances 0.000 description 20
150000001413 amino acids Chemical class 0.000 description 18
241000271566 Aves Species 0.000 description 16
239000013612 plasmid Substances 0.000 description 16
241000286209 Phasianidae Species 0.000 description 15
238000004458 analytical method Methods 0.000 description 15
101710091601 21 kDa protein Proteins 0.000 description 12
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
239000006166 lysate Substances 0.000 description 11
238000003556 assay Methods 0.000 description 10
238000010367 cloning Methods 0.000 description 10
108020004774 Alkaline Phosphatase Proteins 0.000 description 9
241001465754 Metazoa Species 0.000 description 9
108091028043 Nucleic acid sequence Proteins 0.000 description 9
208000015181 infectious disease Diseases 0.000 description 9
238000003780 insertion Methods 0.000 description 9
230000037431 insertion Effects 0.000 description 9
230000035772 mutation Effects 0.000 description 9
230000001105 regulatory effect Effects 0.000 description 9
230000003248 secreting effect Effects 0.000 description 9
239000003981 vehicle Substances 0.000 description 9
102000002260 Alkaline Phosphatase Human genes 0.000 description 8
241000588832 Bordetella pertussis Species 0.000 description 8
241000288147 Meleagris gallopavo Species 0.000 description 8
241000283973 Oryctolagus cuniculus Species 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
210000002919 epithelial cell Anatomy 0.000 description 8
210000000987 immune system Anatomy 0.000 description 8
230000003053 immunization Effects 0.000 description 8
108020004705 Codon Proteins 0.000 description 7
101710154643 Filamentous hemagglutinin Proteins 0.000 description 7
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
230000028993 immune response Effects 0.000 description 7
238000002649 immunization Methods 0.000 description 7
229930027917 kanamycin Natural products 0.000 description 7
229960000318 kanamycin Drugs 0.000 description 7
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
229930182823 kanamycin A Natural products 0.000 description 7
230000004044 response Effects 0.000 description 7
108091008146 restriction endonucleases Proteins 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
241000894007 species Species 0.000 description 7
210000003437 trachea Anatomy 0.000 description 7
210000005062 tracheal ring Anatomy 0.000 description 7
GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 6
101710134681 40 kDa protein Proteins 0.000 description 6
229920001817 Agar Polymers 0.000 description 6
241000282412 Homo Species 0.000 description 6
239000008272 agar Substances 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000012217 deletion Methods 0.000 description 6
230000037430 deletion Effects 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
239000002609 medium Substances 0.000 description 6
GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 6
244000052769 pathogen Species 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
101710118202 43 kDa protein Proteins 0.000 description 5
101710108485 Envelope phospholipase F13 Proteins 0.000 description 5
101710102044 Envelope protein F13 homolog Proteins 0.000 description 5
239000004098 Tetracycline Substances 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
239000013611 chromosomal DNA Substances 0.000 description 5
239000000287 crude extract Substances 0.000 description 5
230000000694 effects Effects 0.000 description 5
230000006870 function Effects 0.000 description 5
230000036039 immunity Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
210000001322 periplasm Anatomy 0.000 description 5
239000000047 product Substances 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
238000010561 standard procedure Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
229960002180 tetracycline Drugs 0.000 description 5
229930101283 tetracycline Natural products 0.000 description 5
235000019364 tetracycline Nutrition 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
108060003951 Immunoglobulin Proteins 0.000 description 4
108010052285 Membrane Proteins Proteins 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
108010081690 Pertussis Toxin Proteins 0.000 description 4
108010076504 Protein Sorting Signals Proteins 0.000 description 4
241000251539 Vertebrata <Metazoa> Species 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
230000001464 adherent effect Effects 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
230000027455 binding Effects 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
235000013601 eggs Nutrition 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
239000000499 gel Substances 0.000 description 4
230000012010 growth Effects 0.000 description 4
102000018358 immunoglobulin Human genes 0.000 description 4
229940099472 immunoglobulin a Drugs 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
238000011081 inoculation Methods 0.000 description 4
238000002703 mutagenesis Methods 0.000 description 4
231100000350 mutagenesis Toxicity 0.000 description 4
108091033319 polynucleotide Proteins 0.000 description 4
102000040430 polynucleotide Human genes 0.000 description 4
239000002157 polynucleotide Substances 0.000 description 4
230000009257 reactivity Effects 0.000 description 4
238000012216 screening Methods 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
239000000758 substrate Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
238000013519 translation Methods 0.000 description 4
108010077805 Bacterial Proteins Proteins 0.000 description 3
208000018150 Bordetella infection Diseases 0.000 description 3
241000588780 Bordetella parapertussis Species 0.000 description 3
241000283707 Capra Species 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
239000006142 Luria-Bertani Agar Substances 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
108020005187 Oligonucleotide Probes Proteins 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
239000000443 aerosol Substances 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
238000009472 formulation Methods 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
238000001502 gel electrophoresis Methods 0.000 description 3
210000004907 gland Anatomy 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
239000002054 inoculum Substances 0.000 description 3
238000013507 mapping Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
238000007899 nucleic acid hybridization Methods 0.000 description 3
150000007523 nucleic acids Chemical group 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
239000002751 oligonucleotide probe Substances 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
150000003522 tetracyclines Chemical class 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
206010059837 Adhesion Diseases 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
239000001987 Bordet-Gengou agar Substances 0.000 description 2
241000588779 Bordetella bronchiseptica Species 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
241001494479 Pecora Species 0.000 description 2
206010051497 Rhinotracheitis Diseases 0.000 description 2
241001138501 Salmonella enterica Species 0.000 description 2
241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 description 2
241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
241000607683 Salmonella enterica subsp. enterica serovar Pullorum Species 0.000 description 2
241000701835 Salmonella virus P22 Species 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
108010008038 Synthetic Vaccines Proteins 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
241000700605 Viruses Species 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
230000005875 antibody response Effects 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
101150107204 asd gene Proteins 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
239000003593 chromogenic compound Substances 0.000 description 2
210000000215 ciliated epithelial cell Anatomy 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
239000003651 drinking water Substances 0.000 description 2
235000020188 drinking water Nutrition 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
210000003495 flagella Anatomy 0.000 description 2
239000012530 fluid Substances 0.000 description 2
-1 for example Chemical class 0.000 description 2
230000004927 fusion Effects 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
210000002443 helper t lymphocyte Anatomy 0.000 description 2
108010037896 heparin-binding hemagglutinin Proteins 0.000 description 2
NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
238000000099 in vitro assay Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
210000003563 lymphoid tissue Anatomy 0.000 description 2
230000013011 mating Effects 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
210000002850 nasal mucosa Anatomy 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
238000002515 oligonucleotide synthesis Methods 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
101150009573 phoA gene Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
238000001742 protein purification Methods 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
229940124551 recombinant vaccine Drugs 0.000 description 2
238000012552 review Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
229940079862 sodium lauryl sarcosinate Drugs 0.000 description 2
ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
239000000243 solution Substances 0.000 description 2
229960000268 spectinomycin Drugs 0.000 description 2
UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000017105 transposition Effects 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
230000035899 viability Effects 0.000 description 2
230000004580 weight loss Effects 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
WONRDHPFOHAWOG-UHFFFAOYSA-N 2-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Cl)C=CC2=C1 WONRDHPFOHAWOG-UHFFFAOYSA-N 0.000 description 1
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
206010003497 Asphyxia Diseases 0.000 description 1
201000008283 Atrophic Rhinitis Diseases 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
101000870242 Bacillus phage Nf Tail knob protein gp9 Proteins 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
241000251556 Chordata Species 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
208000000059 Dyspnea Diseases 0.000 description 1
206010013975 Dyspnoeas Diseases 0.000 description 1
101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
241001131785 Escherichia coli HB101 Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108010000916 Fimbriae Proteins Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241000272496 Galliformes Species 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
239000006137 Luria-Bertani broth Substances 0.000 description 1
102000004317 Lyases Human genes 0.000 description 1
108090000856 Lyases Proteins 0.000 description 1
239000007993 MOPS buffer Substances 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108010013639 Peptidoglycan Proteins 0.000 description 1
108010090127 Periplasmic Proteins Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
108091036407 Polyadenylation Proteins 0.000 description 1
108010020346 Polyglutamic Acid Proteins 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 description 1
102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
206010039088 Rhinitis atrophic Diseases 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000277263 Salmo Species 0.000 description 1
241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 description 1
241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
101000870345 Vasconcellea cundinamarcensis Cysteine proteinase 1 Proteins 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
210000004712 air sac Anatomy 0.000 description 1
230000004075 alteration Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000009830 antibody antigen interaction Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
WXNRAKRZUCLRBP-UHFFFAOYSA-N avridine Chemical compound CCCCCCCCCCCCCCCCCCN(CCCN(CCO)CCO)CCCCCCCCCCCCCCCCCC WXNRAKRZUCLRBP-UHFFFAOYSA-N 0.000 description 1
229950010555 avridine Drugs 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
210000005252 bulbus oculi Anatomy 0.000 description 1
108091006374 cAMP receptor proteins Proteins 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
230000001886 ciliary effect Effects 0.000 description 1
210000000254 ciliated cell Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
229940095074 cyclic amp Drugs 0.000 description 1
230000016396 cytokine production Effects 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
235000019800 disodium phosphate Nutrition 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000000635 electron micrograph Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
229940096118 ella Drugs 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000009313 farming Methods 0.000 description 1
239000003517 fume Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
244000053095 fungal pathogen Species 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
235000011167 hydrochloric acid Nutrition 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000017555 immunoglobulin mediated immune response Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229940090044 injection Drugs 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000016379 mucosal immune response Effects 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
239000006179 pH buffering agent Substances 0.000 description 1
230000021962 pH elevation Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
210000001986 peyer's patch Anatomy 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920002643 polyglutamic acid Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
206010037833 rales Diseases 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
235000017709 saponins Nutrition 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
230000035322 succinylation Effects 0.000 description 1
238000010613 succinylation reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000000856 sucrose gradient centrifugation Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
238000002627 tracheal intubation Methods 0.000 description 1
210000005092 tracheal tissue Anatomy 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
230000010415 tropism Effects 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000001018 virulence Effects 0.000 description 1
230000001755 vocal effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

CA 2013571 1989-03-31 1990-03-30 Vaccins contre bordetella Abandoned CA2013571A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33264189A	1989-03-31	1989-03-31
US332,641		1989-03-31

Publications (1)

Publication Number	Publication Date
CA2013571A1 true CA2013571A1 (fr)	1990-09-30

Family

ID=23299163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2013571 Abandoned CA2013571A1 (fr)	1989-03-31	1990-03-30	Vaccins contre bordetella

Country Status (1)

Country	Link
CA (1)	CA2013571A1 (fr)

1990
- 1990-03-30 CA CA 2013571 patent/CA2013571A1/fr not_active Abandoned

Publication	Publication Date	Title
JP3004049B2 (ja)	2000-01-31	病原性のないｐｈｏＰ型微生物を含有するワクチン
JP3633933B2 (ja)	2005-03-30	弱毒化細菌における組換え融合タンパク質の発現
AU745003B2 (en)	2002-03-07	Live attenuated vaccines
JP3380559B2 (ja)	2003-02-24	ヘリコバクター・ピロリ抗原及びワクチン組成物
CA1338705C (fr)	1996-11-12	Vaccins obtenus a partir de genes, antigenes de genes recombinants
CA2323634A1 (fr)	1999-09-23	Lactobacillus hebergeant des genes d'agregation cellulaire et de fixation de mucine, en tant que vehicules d'apport de vaccins
AU5432690A (en)	1990-11-05	Bordetella vaccines
US5747309A (en)	1998-05-05	Bacterial vaccines using vaccine strains of pathogenic bacteria
JPH07507688A (ja)	1995-08-31	ジフテリア毒素ワクチン
JP2004159660A (ja)	2004-06-10	コレラワクチンとしての欠失変異体
US5238823A (en)	1993-08-24	Interleukin-2-leukotoxin gene fusions and uses thereof
Cárdenas et al.	1993	Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors
US5521072A (en)	1996-05-28	Actinobacillus pleuropneumoniae transferrin binding proteins and uses thereof
US6096320A (en)	2000-08-01	Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica
US5273889A (en)	1993-12-28	Gamma-iterferon-leukotoxin gene fusions and uses thereof
US6902736B2 (en)	2005-06-07	Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
Gentry-Weeks et al.	1992	Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium
US5874088A (en)	1999-02-23	Deletion mutants of cholera vaccines expressing heterologous antigens
US5441736A (en)	1995-08-15	Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
US20020028210A1 (en)	2002-03-07	Vaccine composition comprising helicobacter pylori flagellin polypeptide
CA2013571A1 (fr)	1990-09-30	Vaccins contre bordetella
US5798103A (en)	1998-08-25	Whooping cough vaccine comprising a fimbria protein
US20010018055A1 (en)	2001-08-30	Deletion mutants of virulence factors of pasteurellaceae
Freytag	1991	Effect of gene location on in vitro and in vivo stability, immunogenicity and expression of foreign antigens in bacterial vaccine fectors
Guzmàn et al.	1993	Use of Salmonella Spp. Carrier Strains to Deliver Bordetella Pertussis Antigens in Mice using the oral Route

Legal Events

Date	Code	Title	Description
1994-09-30	FZDE	Dead